How Innovative Partnerships & New Pharmacy Models Can Help Health Systems Address Rising Drug Costs While Improving Patient Access and Affordability

Innovative partnerships and new pharmacy models are emerging as potential solutions to the rising costs of prescription drugs, which are becoming a significant concern for health systems. Leaders from Lumicera Health Services and Clairventa discuss how their organizations aim to address these challenges by enhancing patient access and affordability. Eric Huckins, Chief Growth Officer at Lumicera, emphasizes the importance of understanding the complexities of drug pricing and the various stakeholders involved in the supply chain, while Michael DePaz, Vice President of Supply Chain Specialty Pharmacy at Clairventa, introduces Clairventa as a procurement group purchasing organization (GPO) designed to increase transparency and efficiency in drug pricing.

Clairventa seeks to revolutionize the supply chain by minimizing the value lost to middlemen, thereby enabling health systems to procure medications at lower net prices. This approach aims to alleviate margin compression faced by health systems and improve their financial sustainability. Jamie Paulskill, Director of Manufacturer Relations and Contracting at Clairventa, adds that the initiative will also enhance patient care by potentially lowering out-of-pocket costs for medications, which could lead to better medication adherence and overall health outcomes.

The leaders express optimism about the future of the healthcare industry, highlighting that legislative changes are pushing for greater transparency in drug pricing. They believe that Clairventa's model will not only benefit health systems but also create a more equitable environment for patients needing medications. As the healthcare landscape evolves, the collaboration among various stakeholders is seen as crucial for driving down costs and improving access to essential treatments.

In this episode, Eric Huckins, Chief Growth Officer, Lumicera Health Services, Michael DePaz, Vice President of Supply Chain Specialty Pharmacy, Clarventa, and Jamie Palzkill, Director of Manufacturer Relations & Contracting, Clarventa, discuss rising drug costs, supply chain transparency, and the launch of Clarventa’s net-price procurement model. They explore how innovative partnerships can help health systems reduce costs, improve medication access, and create a more sustainable pharmacy ecosystem for patients and providers.

This episode is sponsored by Lumicera Health Services and Clarventa.